Siemens Fonds Invest GmbH Grows Stock Holdings in The Clorox Company (NYSE:CLX)

Siemens Fonds Invest GmbH grew its holdings in The Clorox Company (NYSE:CLX) by 584.8% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 8,895 shares of the company’s stock after acquiring an additional 7,596 shares during the period. Siemens Fonds Invest GmbH’s holdings in Clorox were worth $1,445,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in CLX. Vanguard Group Inc. lifted its holdings in shares of Clorox by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company’s stock valued at $2,518,517,000 after acquiring an additional 124,428 shares during the last quarter. Geode Capital Management LLC raised its position in Clorox by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company’s stock valued at $501,925,000 after purchasing an additional 69,969 shares during the period. Stifel Financial Corp raised its position in Clorox by 0.4% during the fourth quarter. Stifel Financial Corp now owns 2,344,408 shares of the company’s stock valued at $380,761,000 after purchasing an additional 9,582 shares during the period. Norges Bank bought a new stake in shares of Clorox in the 4th quarter valued at approximately $259,041,000. Finally, Northern Trust Corp boosted its holdings in shares of Clorox by 18.2% in the 4th quarter. Northern Trust Corp now owns 1,494,265 shares of the company’s stock worth $242,684,000 after purchasing an additional 230,173 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber bought 4,000 shares of the business’s stock in a transaction on Wednesday, May 7th. The shares were acquired at an average price of $136.57 per share, with a total value of $546,280.00. Following the transaction, the director now owns 4,000 shares of the company’s stock, valued at approximately $546,280. This trade represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.57% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities analysts have recently weighed in on CLX shares. Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Barclays cut their price objective on shares of Clorox from $134.00 to $129.00 and set an “underweight” rating on the stock in a research report on Wednesday, May 7th. JPMorgan Chase & Co. reduced their target price on shares of Clorox from $151.00 to $144.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 6th. Citigroup dropped their price target on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a research note on Monday, April 14th. Finally, Evercore ISI set a $140.00 price target on shares of Clorox and gave the company an “underperform” rating in a report on Tuesday, May 6th. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $151.23.

Clorox Stock Performance

Clorox stock opened at $136.31 on Friday. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The company has a market capitalization of $16.80 billion, a PE ratio of 37.24, a P/E/G ratio of 2.62 and a beta of 0.60. The company has a 50 day moving average price of $141.05 and a 200-day moving average price of $153.35. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a return on equity of 316.87% and a net margin of 6.38%. The firm had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.74 billion. During the same quarter in the previous year, the business earned $1.71 earnings per share. The company’s revenue for the quarter was down 8.0% compared to the same quarter last year. As a group, equities analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 9th. Investors of record on Wednesday, April 23rd were issued a $1.22 dividend. The ex-dividend date of this dividend was Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.58%. Clorox’s payout ratio is currently 87.61%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.